Catalent Pharma Solutions’ Post

Discover advanced GMP-compatible procedures that ensure simplified, robust, and scalable workflows. Dive into the evolution of protocols for generating clinically relevant cell types from induced pluripotent stem cells (iPSCs). #iPSCells #StemCellResearch #GMP #Biotech #CellTherapy https://ow.ly/Toq350SwXIk

Discover advanced GMP-compatible procedures that ensure simplified, robust, and scalable workflows. Dive into the evolution of protocols for generating clinically relevant cell types from induced pluripotent stem cells (iPSCs). #iPSCells #StemCellResearch #GMP #Biotech #CellTherapy https://ow.ly/G5FC50Spl4A

It's #BuzzTechTuesday! Check out this Georgia Institute of Technology microfluidic innovation that quickly and efficiently separates intact cell colonies for selective isolation and purification of stem cells for research and regenerative therapeutics. Learn more about it! #hipsc #microfluidics #regenerativetherapies #stemcells https://ow.ly/INiE50RTYCo

Discover advanced GMP-compatible procedures that ensure simplified, robust, and scalable workflows. Dive into the evolution of protocols for generating clinically relevant cell types from induced pluripotent stem cells (iPSCs). #iPSCells #StemCellResearch #GMP #Biotech #CellTherapy https://ow.ly/nhFj50Syc3C

Discover advanced GMP-compatible procedures that ensure simplified, robust, and scalable workflows. Dive into the evolution of protocols for generating clinically relevant cell types from induced pluripotent stem cells (iPSCs). #iPSCells #StemCellResearch #GMP #Biotech #CellTherapy https://ow.ly/G5FC50Spl4A

Discover advanced GMP-compatible procedures that ensure simplified, robust, and scalable workflows. Dive into the evolution of protocols for generating clinically relevant cell types from induced pluripotent stem cells (iPSCs). #iPSCells #StemCellResearch #GMP #Biotech #CellTherapy https://ow.ly/nhFj50Syc3C

Do you want to expand and differentiate human pluripotent stem cells (PSCs) into cardiomyocytes with minimal hands-on time? Our CliniMACS Prodigy® Adherent Cell Culture enables you to accomplish exactly this – in a closed system with a high degree of automation. This not only helps you to save precious time, but also minimizes open handling steps and thereby protects your valuable cells. The process includes nine modules representing different workflow steps such as coating, inoculation, media change, cell passaging, and harvesting. This smart modularization allows you to adjust the process to your protocol easily. Take your manufacturing of PSC-derived cardiomyocytes to the next level! ℹ️ More info: https://lnkd.in/gq86s4YC 📝 Application Note:  https://lnkd.in/g27SB5v5 For more inquiries, kindly contact marketing@canvio.net or 010-260 7228. #miltenyibiotec

🔬 Understanding cell potency: multipotent, totipotent, pluripotent cells. Dive into the distinctions: ➡ Multipotent cells specialize. ➡ Totipotent cells are ultra-versatile. ➡ Pluripotent cells offer broad potential. Join the discussion on cell potency levels or explore stem cell differentiation further! Let's broaden our understanding together. #CellBiology #StemCells #Research #researchanddevelopment #biotech #biotechnology #sciencecommunication #preclinical #preclinicalresearch

Where were you 10 years ago? On January 27, 2014 was published in Nature Portfolio Communications a groundbreaking article on #laminin521. 🎉 Rodin et al. 2014 described for the first time the improved derivation and survival of #hPSC on human recombinant #fulllength laminin proteins, by re-creating in the human embryonic stem cells microenvironment of the blastocyst inner cell mass. From all the substrates tested, only laminin 521 supported long-term self-renewal of the cells in completely defined and xeno-free environment and their efficient clonal expansion without the use of Rock inhibitor (Y-27632). The described method for a fully defined xeno-free culture system for hPSC paved the way for the development of modern cell and #advancedtherapies as well as drug development and discovery. Check below the key takings of the article! Learn more ➡ https://lnkd.in/d-5wyH3g

We are so excited to announce our new partnership with growth factor manufacturer, Qkine! This collaboration will combine the expertise in complex protein manufacturing and engineering of Qkine with StemCultures, LLC. proprietary controlled-release technologies to develop new reagents for precision stem cell expansion and differentiation. "We are beginning to tackle the complexities of stem cell culture, where growth factors—proteins that provide essential signals to stem cells—degrade at varying rates, are inhibited by natural inhibitors accumulating in the culture, and are sequestered, leading to a fundamental lack of control over culture conditions. This lack of control affects the quality of data and scalability for disease models and the development of cell therapies." Dr. Catherine Elton, CEO and Founder of Qkine. #stemcells #organoids #growthfactors